The effectiveness of CUDC101 and IR780 provide synergistic anti-tumor effects via photosensitizer-based photodynamic therapy and drug-induced CD47 suppression, demonstrating reprogramming to M1-type TAMs (Figure 5B,D). This evidence concerns the gene CD47 and neoplasm.